Safety of Nebulized Combination Therapy BromAc® in COVID-19 Respiratory Disease

NCT05258682 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19 Pneumonia
COVID-19
Ventilator Associated Pneumonia
COVID-19 Acute Respiratory Distress Syndrome

Interventions

DRUG: Bromelains
DRUG: Acetylcysteine

Sponsor

Mucpharm Pty Ltd

Collaborators

[object Object]